Clinical Trial Update: Memantine in Bipolar Patients With Alcoholism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for memantine in bipolar patients with alcoholism is reported, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Bipolar Disorder

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: AOD Effects and Consequences | Phase 3 | Status: UNKNOWN